---
title: "Sotera Health Co. Secures Amended Credit Agreement with JPMorgan, Reducing Interest Rate Spread by 0.50% on $1.423 Billion Loan"
description: "Sotera Health Co. has amended its First Lien Credit Agreement with JPMorgan, reducing the interest rate spread by 0.50% on a $1.423 billion loan. The amendment, effective September 17, 2025, involves "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/257977830.md"
published_at: "2025-09-18T21:02:23.000Z"
---

# Sotera Health Co. Secures Amended Credit Agreement with JPMorgan, Reducing Interest Rate Spread by 0.50% on $1.423 Billion Loan

> Sotera Health Co. has amended its First Lien Credit Agreement with JPMorgan, reducing the interest rate spread by 0.50% on a $1.423 billion loan. The amendment, effective September 17, 2025, involves a repayment of $75 million in outstanding borrowings and sets the interest margin at Adjusted Term SOFR plus 2.50%. The loans include a 1.00% soft call premium within six months and will amortize at 1.00% per annum, maturing on May 30, 2031.

Sotera Health Co. has amended its existing First Lien Credit Agreement, originally dated December 13, 2019, by entering into Amendment No. 6 on September 17, 2025. This amendment, involving Sotera Health Holdings, LLC, certain subsidiaries, and refinancing term lenders, including JPMorgan Chase Bank as the administrative agent, introduces significant changes. The refinancing lenders will provide term loans totaling $1,423,029,875, reflecting a repayment of $75 million in outstanding borrowings. Additionally, the amendment reduces the interest rate spread by 0.50% for term loans, setting the interest margin at Adjusted Term SOFR plus 2.50%. The loans also feature a “soft call” premium of 1.00% within six months of the amendment’s effective date, amortizing at 1.00% per annum with a maturity date of May 30, 2031. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sotera Health Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-207549), on September 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SHC.US - Sotera Health](https://longbridge.com/en/quote/SHC.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Insights into Sotera Health Q4 Earnings | Sotera Health (NASDAQ:SHC) reported Q4 earnings on February 24, 2026, beating estimates by 13.04% with an EPS of $0.26 c | [Link](https://longbridge.com/en/news/276732566.md) |
| Sotera Health (SHC) Margin Expansion To 6.7% Tests Premium 60.9x P/E Narrative | Sotera Health (SHC) reported Q4 FY 2025 revenue of $303.4 million and basic EPS of $0.12, concluding a year with $1.2 bi | [Link](https://longbridge.com/en/news/276806603.md) |
| Sotera Health Q4 revenue beats expectations on sterigenics segment's growth | Sotera Health reported a 4.6% increase in Q4 revenue, surpassing analyst expectations, with adjusted EPS rising by $0.05 | [Link](https://longbridge.com/en/news/276732078.md) |
| U.S. 1-year, 11-month floating rate notes high margin 0.099% | The U.S. Treasury Department reported the results of its Dutch auction for 1-year, 11-month floating rate notes, with a  | [Link](https://longbridge.com/en/news/276915198.md) |
| Credit Spreads May Get A Rude Awakening From Stock Correlation | Authored by Simon White, Bloomberg macro strategist,Becalmed credit spreads would move abruptly higher if stocks experie | [Link](https://longbridge.com/en/news/276469020.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.